Word

QELZEG

Status

Pending

Status Code

688

Status Date

Tuesday, February 13, 2024

Serial Number

97799392

Mark Type

4000

Filing Date

Friday, February 17, 2023

Published for Opposition

Tuesday, December 19, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events

Feb 13, 2024

Noa E-Mailed - Sou Required From Applicant

Dec 19, 2023

Official Gazette Publication Confirmation E-Mailed

Dec 19, 2023

Published For Opposition

Nov 29, 2023

Notification Of Notice Of Publication E-Mailed

Nov 16, 2023

Approved For Pub - Principal Register

Nov 16, 2023

Assigned To Examiner

Feb 23, 2023

New Application Office Supplied Data Entered

Feb 21, 2023

New Application Entered